Tag: India

Italian API manufacturer buys a production facility in India

Olon, an API contract development and manufacturing organization and generics supplier, announced the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India.

GeneSys Biologics launches an integrated drug development facilty

GeneSys Biologics, an Indian biotechnology company based in Hyderabad, launched its integrated drug development facility in Genome Valley, Shameerpet (India).

India aimed to combat with counterfeit drugs using blockchain technology

Indian policymakers in collaboration with an Indian hospital chain and a multinational technology corporation have initiated plans to deploy blockchain in the fight against counterfeit drugs.

Novo Nordisk Pharmatech signs a distribution agreement with Signet

Novo Nordisk
Novo Nordisk Pharmatech has entered into an agreement with Signet Chemical for the distribution of their pharmaceutical range of quaternary ammonium compounds in India, Bangladesh and Sri Lanka.

Iran and India will conduct 12 joint research projects

research lab
Based on previous Memoranda of Understanding inked by the two countries, 12 different joint research projects in the fields of biotechnology and water management will be carried out.

Indian pharma companies obtained 125 FDA approvals during H1 2018

Indian Pharma companies and their subsidiaries have received 125 final ANDA approvals from US FDA during the first half ended June 2018 out of total 323 Abbreviated New Drug Applications approvals.

ACG became India’s first complete packaging solution provider for OSD drugs

With the launch of the state-of-the-art lamination facility at Shirwal near Pune, ACG has become India’s first complete packaging solution provider for oral solid dosage formulation.

Indian pharmaceutical companies intend to enter the Russian market

Indian companies, including Advance Pharma, Hetero Labs, and Sun Pharma, intend to enter the Russian pharmaceutical market, said Shubham Kumar, the Consul General of India in Vladivostok.

Indian pharma company is looking for a construction site in Ingushetia

india pharma
Gogineni Vijayakumar, General Director of Varthamana International Traders has arrived in the Republic of Ingushetia. The Chairman of the Government of the Republic of Ingushetia held a working meeting.

China will conduct regulatory trainings for Indian pharma companies

china street
China has agreed to conduct specific training programmes for Indian pharmaceutical companies to understand their regulatory system, which will promote India's exports from the sector.

The Indian government will set a new drug policy and rules for clinical trials

A team of Indian officials led by Dr. G N Singh, Drug Controller General of India, informed that a set of new procedures to facilitate clinical trials are expected to be unveiled shortly.

Omnicare Drugs India and ASKA Pharmaceuticals set up a joint venture

Omnicare Drugs India, an arm of the UAE-based Neopharma LLC, and Japan’s ASKA Pharmaceuticals have inked an agreement to establish a joint venture (JV) in India.

India aims to stimulate local API manufacturing

india pharma
In a bid to reduce India’s dependence on China for active pharmaceutical ingredients, the chemicals and fertilizers Indian ministry has joined hands with other ministries to draw up a road map for increasing their production.

AstraZeneca will invest $90 million in India during the next five years

Leading global science-led biopharmaceutical company AstraZeneca announced its decision of further investing $90 million over the next 5 years in India.

Indian scientists developed an Ayurvedic dengue drug

The Central Council for Research in Ayurvedic Sciences (CCRAS, India) and regional research centre in Karnataka’s Belgaum (India) have started conducting pilot studies for the medicine that have been proved clinically safe.

The Government of India submitted a draft amendment on cell therapies

stem cells
The Ministry of Health and Family Welfare of India, after consultations with the Drugs Technical Advisory Board (DTAB), has proposed a draft amendment that defines stem cell-based products (SCBP).